Canadian International Development Agency Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Canada (1968)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2001
NCT00198822
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 3)

Diarrhea (Phase 4)

Infant Death (Phase 3)

Malaria (Phase 4)

Maternal Death (Phase 3)

Night Blindness (Phase 3)

Vaginal Discharge (Phase 3)

Vaginal Diseases (Phase 3)

Vaginitis (Phase 3)

Vaginosis, Bacterial (Phase 3)

Vitamin A Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8